Loading company…
Zhejiang Arthur Pharmaceutical develops and supplies generic and innovative medicines.
Founded in 2020 and based in Jiaxing, Zhejiang Arthur Pharmaceutical develops oral, sterile and semi-solid medicines for several therapeutic areas. It also offers CRO, CMO and CDMO services. In June 2024, the company closed Series B funding and reported research centers in the United States and Jiaxing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in